Trials / Active Not Recruiting
Active Not RecruitingNCT07011485
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
A Triple-Blind, Randomized, Efficacy and Tolerability Comparison Study of PDFE-2304 Topical Solution Versus Minoxidil 5% Topical Solution for the Treatment of Androgenic Alopecia (AGA).
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- PDFE Pharma Innovations FZCO · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of PDFE-2304 compared with Minoxidil 5% in men with androgenic alopecia (AGA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Minoxidil 5% Topical Solution | Approximately one mL dose applied onto a pre-specified scalp area twice daily for 16 weeks. |
| DRUG | PDFE-2304 Topical Solution | Approximately one mL dose applied onto a pre-specified scalp area twice daily for 16 weeks. |
Timeline
- Start date
- 2025-05-14
- Primary completion
- 2025-08-14
- Completion
- 2025-09-17
- First posted
- 2025-06-08
- Last updated
- 2025-06-08
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT07011485. Inclusion in this directory is not an endorsement.